Found: 19
Select item for more details and to access through your institution.
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
- Published in:
- Diabetologia, 2007, v. 50, n. 8, p. 1752, doi. 10.1007/s00125-007-0710-4
- By:
- Publication type:
- Article
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro<sup>3</sup>)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
- Published in:
- Diabetologia, 2007, v. 50, n. 7, p. 1532, doi. 10.1007/s00125-007-0692-2
- By:
- Publication type:
- Article
Effects of the novel (Pro<sup>3</sup>)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin V.A. Gault et al.: GIP receptor antagonist
- Published in:
- Diabetologia, 2003, v. 46, n. 2, p. 222, doi. 10.1007/s00125-002-1028-x
- By:
- Publication type:
- Article
Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP F.P.M. O'Harte et al.: Bioactive gastric inhibitory polypeptide analogues.
- Published in:
- Diabetologia, 2002, v. 45, n. 9, p. 1281, doi. 10.1007/s00125-002-0894-6
- By:
- Publication type:
- Article
EDUCATIONAL INTELLIGENCE: COLORADO. .
- Published in:
- Journal of Education, 1887, v. 25, n. 1, p. 13
- By:
- Publication type:
- Article
Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 10, p. 891, doi. 10.1111/j.1463-1326.2010.01259.x
- By:
- Publication type:
- Article
Daily administration of the GIP-R antagonist (Pro<sup>3</sup>)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti–obesity-diabetes actions of (Pro<sup>3</sup>)GIP.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 4, p. 336, doi. 10.1111/j.1463-1326.2007.00712.x
- By:
- Publication type:
- Article
A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, n. 5, p. 595, doi. 10.1111/j.1463-1326.2004.00455.x
- By:
- Publication type:
- Article
A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.
- Published in:
- Diabetologia, 2013, v. 56, n. 6, p. 1417, doi. 10.1007/s00125-013-2892-2
- By:
- Publication type:
- Article
RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes.
- Published in:
- Diabetic Medicine, 2018, v. 35, n. 1, p. 33, doi. 10.1111/dme.13522
- By:
- Publication type:
- Article
Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 887, doi. 10.1111/dom.12508
- By:
- Publication type:
- Article
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 403, doi. 10.1111/dom.12432
- By:
- Publication type:
- Article
Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
- Published in:
- International Journal of Obesity, 2013, v. 37, n. 5, p. 678, doi. 10.1038/ijo.2012.91
- By:
- Publication type:
- Article
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet.
- Published in:
- International Journal of Obesity, 2010, v. 34, n. 8, p. 1341, doi. 10.1038/ijo.2010.59
- By:
- Publication type:
- Article
Actions of prolonged glucagon-like peptide-1 receptor activation on cognitive function in a model of diet-induced obesity.
- Published in:
- Proceedings of the Nutrition Society, 2010, v. 69, n. OCE5, p. 12, doi. 10.1017/S0029665110002144
- By:
- Publication type:
- Article
(Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Xenin-25[LysPAL]: a novel long-acting acylated analogue of xenin-25 with promising antidiabetic potential.
- Published in:
- Acta Diabetologica, 2015, v. 52, n. 3, p. 461, doi. 10.1007/s00592-014-0681-0
- By:
- Publication type:
- Article
N-terminally modified degradation resistant analogues of glucose-dependent insulinotropic polypeptide display enhanced antidiabetic action.
- Published in:
- Irish Journal of Medical Science, 2002, v. 171, p. 9, doi. 10.1007/BF03170226
- By:
- Publication type:
- Article
Receptor antagonist studies indicate that GIP is a more important enteroinsular axis hormone than GLP-1 in obese diabetic (OB/OB) mice.
- Published in:
- Irish Journal of Medical Science, 2002, v. 171, p. 18, doi. 10.1007/BF03170244
- By:
- Publication type:
- Article